Volume 17, Number 6—June 2011
Dispatch
Outcome Predictors in Treatment of Yaws
Table 2
Association between characteristics of case-patients and Treponema pertenue infection treatment failure, Papua New Guinea, January–September 2009*
Characteristic | No. (%) patients treated |
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|---|---|
Success, n = 114 | Failure, n = 24 | OR (95% CI) | p value | OR (95% CI) | p value | |||
Mean age, y (SD) | 9.54 (4.69) | 10.13 (2.96) | 0.58 (−1.39 to 2.56) | 0.56 | NA | NA | ||
Male sex | 69 (60.5) | 12 (50.0) | 0.65 (0.27–1.58) | 0.34 | NA | NA | ||
Lived in a high-incidence village | 69 (60.5) | 21 (87.5) | 4.57 (1.29–16.20) | 0.02 | 3.75 (1.02–13.76) | 0.04 | ||
Secondary yaws | 49 (43.0) | 14 (58.3) | 1.86 (0.76–4.53) | 0.17 | 1.01 (0.37–2.75) | 0.99 | ||
Clinical healing | 108 (94.7) | 24 (100.0) | NA | 0.59 | NA | NA | ||
Positive family history | 27 (23.7) | 9 (37.5) | 1.93 (0.76–4.91) | 0.17 | 1.91 (0.70–5.28) | 0.20 | ||
VDRL titer <32 | 67 (58.8) | 21 (87.5) | 4.91 (1.39–17.41) | 0.01 | 4.05 (1.06–15.38) | 0.04 |
*p<0.05 was considered significant. OR, odds ratio; CI, confidence interval; NA, not applicable; VDRL, Venereal Disease Research Laboratory test.
Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.